Echo Therapeutics files to delay Form 10-KDue to the departure of senior management, and the resignation of the company's auditors in December 2014, and the hiring of a new CEO and CFO in late December 2014, an immediate and necessary corporate relocation from Philadelphia, a rehiring of critical research personnel in Massachusetts as well as sourcing and hiring of new auditors in February 2015, the company will be unable to finalize and file its annual report on Form 10-K by March 31 without unreasonable effort or expense. The company intends to file such report no later than fifteen days after its original prescribed due date.